The Power of PancraGEN
PancraGEN is a personalized molecular pathology test, that interrogates cumulative oncogene and tumor suppressor gene damage, reporting results in the context of each patient’s clinical history, imaging, fluid chemistry and cytology test results. Offering added clarity about the biologic behavior of a pancreatic cyst, PancraGEN provides an overall prognostic assessment that helps inform the best step forward when determining which patients are suited for surveillance vs. surgical intervention.
Gain Powerful Insight for Better Long-term Management
Overseen by expert molecular pathologists who have examined DNA aberrations in >25,000 pancreatic cyst patients, PancraGEN’s ability to accurately inform patient management decisions is also supported by long-term follow-up patient outcomes data (up to 8 years). Results provide deep insight into appropriate surveillance intervals or surgical approaches. Allowing you to more confidently manage patients over time, often with less aggressive treatment pathways.